This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

1. Home cardiorespiratory monitoring should not be prescribed to prevent sudden infant death syndrome (SIDS).
2. Home cardiorespiratory monitoring may be warranted for premature infants who are at high risk of recurrent episodes of apnea, bradycardia, and hypoxemia after hospital discharge. The use of home cardiorespiratory monitoring in this population should be limited to approximately 43 weeks’ postmenstrual age or after the cessation of extreme episodes, whichever comes last.
3. Home cardiorespiratory monitoring may be warranted for infants who are technology dependent (tracheostomy, continuous positive airway pressure), have unstable airways, have rare medical conditions affecting regulation of breathing, or have symptomatic chronic lung disease.
4. If home cardiorespiratory monitoring is prescribed, the monitor should be equipped with an event recorder.
5. Parents should be advised that home cardiorespiratory monitoring has not been proven to prevent sudden unexpected deaths in infants.
6. Pediatricians should continue to promote proven practices that decrease the risk of SIDS--supine sleep position, safe sleeping environments, and elimination of prenatal and postnatal exposure to tobacco smoke.

None provided

The type of supporting evidence is not specifically stated for each recommendation.

Not applicable: The guideline was not adapted from another source.

2003 Apr

American Academy of Pediatrics - Medical Specialty Society

American Academy of Pediatrics

Committee on Fetus and Newborn

Committee on Fetus and Newborn, 2002-2003: Lillian R. Blackmon, MD (Chairperson); Daniel G. Batton, MD; Edward F. Bell, MD; William A. Engle, MD; William P. Kanto, Jr, MD; Gilbert I. Martin, MD; Warren N. Rosenfeld, MD; Ann R. Stark, MD

*James A. Lemons, MD (Past Committee Chairperson)

Liaisons: Keith J. Barrington, MD; Jenny Ecord, MS, RNC, NNP, PNP; Laura E. Riley, MD; Kay M. Tomashek, MD; Linda L. Wright, MD

Staff: Jim Couto, MA

*Lead author

Not stated

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years by the authoring body, at which time a recommendation is made that the policy be retired, revised, or reaffirmed without change. Until the Board of Directors approves a revision or reaffirmation, or retires a statement, the current policy remains in effect.

None available

None available

This NGC summary was completed by ECRI on August 18, 2003. The information was verified by the guideline developer on September 8, 2003.

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.